S1P acts as an upstream repressor of the Hippo pathway, inhibiting YAP phosphorylation and activating YAP/TAZ via the S1P-S1PR2 interaction in hepatocellular carcinoma cells (58, 59). Here, S1PR2 is linked to hepatocellular carcinoma.